Quadrapeutics (IMAGE)

Rice University

Quadrapeutics

Caption

The first preclinical study of the anti-cancer technology "quadrapeutics" found it to be 17 times more efficient than conventional chemoradiation therapy against aggressive, drug-resistant head and neck tumors.

Credit

D. Lapotko/Rice University

Usage Restrictions

Must credit: D. Lapotko/Rice University

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.